• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

Filter
Title Search
1 - 25 of 178 Products Sort by Display
Swine and Avian Influenza Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588366
Published
November 20, 2017
Content info
119 Pages
Price
USD 3995
Sample available
Sickle Cell Disease Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588365
Published
November 17, 2017
Content info
77 Pages
Price
USD 3995
Sample available
Gastric and Esophageal Cancer Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588364
Published
November 16, 2017
Content info
244 Pages
Price
USD 3995
Sample available
Cancer Supportive Care Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
588363
Published
November 14, 2017
Content info
128 Pages
Price
USD 3995
Sample available
Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD
Published by
GBI Research
Product code
585550
Published
November 1, 2017
Content info
149 Pages
Price
USD 6995
Sample available
Hemophilia A and B Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Increasing Treatment-Receiving Pool, Launch of Long-Acting Replacement Therapies and Non-factor Therapy
Published by
GBI Research
Product code
399711
Published
November 1, 2017
Content info
133 Pages
Price
USD 4995
Sample available
Frontier Pharma: Renal Diseases - High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease
Published by
GBI Research
Product code
576590
Published
October 3, 2017
Content info
72 Pages
Price
USD 6995
Sample available
Frontier Pharma: Ophthalmology Therapeutics - Gene Therapies and First-in-Class Targets Offer Novel Treatments for Substantial Unmet Needs in a Pipeline Dominated by Angiogenic and Immune Signaling Drugs
Published by
GBI Research
Product code
576589
Published
October 1, 2017
Content info
71 Pages
Price
USD 6995
Sample available
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2023 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth
Published by
GBI Research
Product code
369233
Published
October 1, 2017
Content info
202 Pages
Price
USD 4995
Sample available
Sleep Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564941
Published
September 26, 2017
Content info
76 Pages
Price
USD 3995
Sample available
Pneumonia Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564940
Published
September 26, 2017
Content info
123 Pages
Price
USD 3995
Sample available
Male Health Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564939
Published
September 25, 2017
Content info
125 Pages
Price
USD 3995
Sample available
Colorectal Cancer Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564938
Published
September 22, 2017
Content info
299 Pages
Price
USD 3995
Sample available
Behavioral Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
564937
Published
September 14, 2017
Content info
113 Pages
Price
USD 3995
Sample available
Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes
Published by
GBI Research
Product code
576588
Published
September 13, 2017
Content info
137 Pages
Price
USD 4995
Sample available
Frontier Pharma: Cancer Immunotherapies - First-in-Class Pipeline Dominated by Immunomodulators and PD-1 Like Targets
Published by
GBI Research
Product code
563402
Published
September 1, 2017
Content info
135 Pages
Price
USD 6995
Sample available
Global Respiratory Drugs Market to 2023 - A Changing Therapeutic Landscape as Key Patents Expire and Biologics, Targeted Therapies and CFTR Modulators for Asthma and Cystic Fibrosis Treatment Emerge as Market Growth Drivers
Published by
GBI Research
Product code
563401
Published
September 1, 2017
Content info
155 Pages
Price
USD 4995
Sample available
Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis
Published by
GBI Research
Product code
550298
Published
August 1, 2017
Content info
113 Pages
Price
USD 6995
Sample available
Hepatitis C Therapeutics in Asia-Pacific Markets to 2023 - Presence of Outstanding Direct-Acting Antivirals and Late-Stage Pipeline to Transform the Clinical and Commercial Landscape
Published by
GBI Research
Product code
550297
Published
August 1, 2017
Content info
138 Pages
Price
USD 4995
Sample available
Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape
Published by
GBI Research
Product code
550296
Published
August 1, 2017
Content info
132 Pages
Price
USD 4995
Sample available
Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
Published by
GBI Research
Product code
550295
Published
August 1, 2017
Content info
79 Pages
Price
USD 6995
Sample available
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537172
Published
August 1, 2017
Content info
254 Pages
Price
USD 3995
Sample available
Hepatitis Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537171
Published
August 1, 2017
Content info
209 Pages
Price
USD 3995
Sample available
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537170
Published
August 1, 2017
Content info
138 Pages
Price
USD 3995
Sample available
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis
Published by
GBI Research
Product code
540334
Published
July 1, 2017
Content info
136 Pages
Price
USD 4995
Sample available